Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like The 3 Absolute Best Biotech Stocks Right Now August 17, 2017 AEterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017 August 6, 2017 Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility February 7, 2018
AEterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017 August 6, 2017
